Skip to content

Pain Control after Root Canal Treatment

Evaluation of Proteolytic Enzymes as an Alternative to Non-Steroidal Anti-inflammatory Drugs for Post-Endodontic Pain following Single Visit Root Canal Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/08/020507
Enrollment
30
Registered
2019-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Serratiopeptidase: Serratiopeptidase is a proteolytic enzyme produced by purification from culture of Serratia E-15 bacteria. Patients will be administered a single postoperative dose o

Sponsors

Pratyasha Kaushik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients above 18 years of age. Patients presenting with pain associated with irreversible pulpitis in mandibular molars with no clinical or radiographic signs or symptoms of acute or chronic apical periodontitis. No history of taking analgesics in the previous 12 hours prior to presenting for treatment. Patients presenting with American Society of Anesthesiologists I or II medical history. Patients providing informed consent. Patients who can read and understand the pain scoring criteria.

Exclusion criteria

Exclusion criteria: Presence of any systemic disorder or sensitivity or allergy that prevents the use of Proteolytic enzymes and NSAIDs. Patients having hepatic and renal disorders. Presence of periapical radiolucency and swelling or any other condition that prevents single-visit root canal treatment. Patients having teeth not suitable for restoration, or having serious periodontal disease that render the teeth unsuitable for endodontic treatment. Pregnant or lactating patients. Teeth will be excluded if there is any overestimation of the working length, inadvertent overinstrumentation through the apical foramen, or extension of the root filling material beyond the working length.

Design outcomes

Primary

MeasureTime frame
Serratiopeptidase may prove to be an effective anti-inflammatory and analgesic agent for post-endodontic pain following single visit root canal treatmentTimepoint: Single dose immediately after endodontic treatment

Secondary

MeasureTime frame
Serratiopeptidase may prove to be as effective as ibuprofen for post-endodontic pain following single visit root canal treatmentTimepoint: Single dose immediately after endodontic treatment

Countries

India

Contacts

Public ContactDr Pratyasha Kaushik

Army College of Dental Sciences

pratyashakaushik2@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026